Product Information
FROVATRIPTAN SUCC 2.5 MG TAB is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $2.7171 per EA under NDC 50742029909. Its NADAC has been published 200 times since Dec 7, 2022.
FDA first approved this application on Apr 6, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742029909
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FROVATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA213891FDA Approved
4/6/2022
TE Code
AB
On Market Since
7/22/2022
Pharmacological Classes
Price Statistics
The NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has been published 200 times since Dec 7, 2022, and over the history we have for it it has declined 67.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7171 per EA |
|---|---|
| All-time high | $12.1187 (Aug 16, 2023) |
| All-time low | $2.7171 (Sep 23, 2026) |
| 52-week high | $3.6263 |
| 52-week low | $2.7171 |
| Median price | $4.3637 |
| Average price | $5.5708 |
| Largest weekly change | +77.7% (Jun 19, 2024) |
| Weeks tracked | 200 |
| Tracking since | Dec 7, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
frovatriptan succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FROVATRIPTAN SUCC 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FROVATRIPTAN SUCC 2.5 MG TAB, manufactured by Ingenus Pharmaceuticals LLC, is $2.7171 per EA (NDC 50742029909), effective Sep 30, 2026.
How has the price of FROVATRIPTAN SUCC 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has declined 67.4%. It has been tracked across 200 weekly CMS publications since Dec 7, 2022.
What are the highest and lowest recorded NADAC prices for FROVATRIPTAN SUCC 2.5 MG TAB?
Since Dec 7, 2022, the NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has ranged from a low of $2.7171 (Sep 23, 2026) to a high of $12.1187 (Aug 16, 2023), with a median of $4.3637 per EA.
Are there cheaper alternatives to FROVATRIPTAN SUCC 2.5 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FROVATRIPTAN SUCC 2.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures FROVATRIPTAN SUCC 2.5 MG TAB?
FROVATRIPTAN SUCC 2.5 MG TAB (NDC 50742029909) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.